French Guiana vs Nicaragua: Share of children with symptoms of a respiratory infection who received antibiotics
French Guiana
45.5%
in 2018
Nicaragua
45.9%
in 2018
French Guiana rank
95th
Nicaragua rank
92nd
Share of children with symptoms of a respiratory infection who received antibiotics over time
- French Guiana
- Nicaragua
How they compare
Nicaragua currently reports 45.9% against 45.5% in French Guiana, a difference of 0.4%.
The two have swapped places 2 times across 19 shared years of data; in 2000 it was Nicaragua ahead.
French Guiana ranks 95th and Nicaragua ranks 92nd of 132 countries.
Across the 2 decades both report, French Guiana averaged higher in 1 and Nicaragua in 1.
Head to head by decade
| Decade | French Guiana | Nicaragua | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 42.0% | 47.3% | 5.3% | Nicaragua |
| 2010s | 44.5% | 43.5% | 1.0% | French Guiana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of children with symptoms of a respiratory infection who received antibiotics, French Guiana or Nicaragua?
- Nicaragua, at 45.9% against 45.5% in French Guiana as of 2018.
- What is the difference in share of children with symptoms of a respiratory infection who received antibiotics between French Guiana and Nicaragua?
- 0.4%, with Nicaragua ahead.
- How many years of comparable data are there for French Guiana and Nicaragua?
- 19 years are reported by both, from 2000 to 2018.
- How do French Guiana and Nicaragua rank globally for share of children with symptoms of a respiratory infection who received antibiotics?
- French Guiana ranks 95th and Nicaragua ranks 92nd of 132 countries.
- Where does this data come from?
- Browne AJ et al. (2021) – processed by Our World in Data, published as Share of children with symptoms of a respiratory infection who received antibiotics. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The caregiver reported share of children under five years old, with symptoms of lower respiratory tract infection, who received antibiotics for this illness.